3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Conditions
Sarcoma
32
Ovarian Neoplasms
12
Leiomyosarcoma
12
Liposarcoma
10
Neoplasms
7
Sarcoma, Ewing
4
Neoplasm Metastasis
4
Liposarcoma, Myxoid
4
Sarcoma, Synovial
3
Rhabdomyosarcoma
3
Histiocytoma, Malignant Fibrous
3
Breast Neoplasms
3
Solitary Fibrous Tumors
2
Sarcoma, Alveolar Soft Part
2
Prostatic Neoplasms
2
Osteosarcoma
2
Neurofibrosarcoma
2
Neoplasms by Site
2
Mesothelioma, Malignant
2
Malignant mesenchymal tumor
2
Ichthyosis, X-Linked
2
Hemangiosarcoma
2
Hemangiopericytoma, Malignant
2
Fibrosarcoma
2
Fallopian Tube Neoplasms
2
Endometrial Neoplasms
2
Bone Neoplasms
2
Wilms Tumor
1
Uterine Neoplasms
1
Unspecified Childhood Solid Tumor, Protocol Specific
1
Interventions
temsirolimus
1
binimetinib
1
Valproic Acid
1
Trabectedin
1
Specimen Handling
1
Sirolimus
1
Laser Therapy
1
Immunoglobulin G
1
Enoxaparin
1
Disulfides
1
Cetuximab
1
Biopsy
1
Bevacizumab
1
Aspirin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Soft Tissue Neoplasms
×
Trabectedin
×
Clear all
NCT02066675
2018-04-11
TR1US
Italian Sarcoma Group
Phase 2
Completed
24 enrolled